Literature DB >> 17415635

Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina.

Max Schmulson1, Orianna Ortiz, Juan Manuel Mejia-Arangure, Yuming B Hu, Carolyn Morris, Denise Arcila, Gabriela Gutierrez-Reyes, Shrikant Bangdiwala, Douglas A Drossman.   

Abstract

The Irritable Bowel Syndrome (IBS)-Quality of Life (QOL) is the most extensively validated health-related quality of life (HRQOL)-specific instrument for IBS with appropriate evidence for psychometric validity. Our aim was to linguistically validate the IBS-QOL for Mexico according to standard guidelines, to conduct further psychometric validation, and to compare the HRQOL between IBS patients from Mexico and North Carolina (University of North Carolina). Construct validity was tested by correlating scores from the Mexican Spanish IBS-QOL with those for anxiety and depression obtained by the Hospital Anxiety and Depression scale. Also, HRQOL from Rome I female IBS patients who consulted a tertiary referral center in Mexico was compared with that of female patients from UNC matched by age and bowel habit. A general univariate linear model was done to determine the most important variable over HRQOL, place of origin, or bowel habit. The majority of the IBS-QOL items had a negative correlation with depression as well as with anxiety. Compared to patients from UNC, the Mexican ones reported significant lower scores on Body Image and Health Worry and a trend in Interference with activities and in the Overall score. There were some differences in Dysphoria and Interference that were related to bowel habit, independently of the place of origin. In conclusion, the IBS-QOL validated in Mexican Spanish has shown construct validity. Using this instrument we found that female IBS patients who consulted a tertiary referral center in Mexico have lower HRQOL than those in North Carolina at least in factors such as Body Image and Health Worry.

Entities:  

Mesh:

Year:  2007        PMID: 17415635     DOI: 10.1007/s10620-006-9689-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Measuring quality of life: Is quality of life determined by expectations or experience?

Authors:  A J Carr; B Gibson; P G Robinson
Journal:  BMJ       Date:  2001-05-19

2.  [Evaluation of health status using Survey SF-36: preliminary results in Mexico].

Authors:  M A Zúniga; G T Carrillo-Jiménez; P J Fos; B Gandek; M R Medina-Moreno
Journal:  Salud Publica Mex       Date:  1999 Mar-Apr

3.  The impact of functional gastrointestinal disorders on quality of life.

Authors:  N A Koloski; N J Talley; P M Boyce
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

4.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  [Accuracy and diagnostic utility of the Hospital Anxiety and Depression Scale (HAD) in a sample of obese Mexican patients].

Authors:  Juan Carlos López-Alvarenga; Verónica Vázquez-Velázquez; Denise Arcila-Martínez; Angel Ernesto Sierra-Ovando; Jorge González-Barranco; Rafael J Salín-Pascual
Journal:  Rev Invest Clin       Date:  2002 Sep-Oct       Impact factor: 1.451

7.  Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases.

Authors:  Lori Frank; Leah Kleinman; Anne Rentz; Gabrielle Ciesla; John J Kim; Christopher Zacker
Journal:  Clin Ther       Date:  2002-04       Impact factor: 3.393

Review 8.  Review article: epidemiology and quality of life in functional gastrointestinal disorders.

Authors:  L Chang
Journal:  Aliment Pharmacol Ther       Date:  2004-11       Impact factor: 8.171

Review 9.  The role of quality of life in functional gastrointestinal disorders: regulatory issues.

Authors:  J F Bergmann; O Chassany
Journal:  Eur J Surg Suppl       Date:  1998

10.  An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

Authors:  J Kellow; O Y Lee; F Y Chang; S Thongsawat; M Z Mazlam; H Yuen; K A Gwee; Y T Bak; J Jones; A Wagner
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more
  12 in total

Review 1.  Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.

Authors:  Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

2.  Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Authors:  Prashant Singh; Kyle Staller; Kenneth Barshop; Elaine Dai; Jennifer Newman; Sonia Yoon; Shahar Castel; Braden Kuo
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Clinical evaluation of Soothing Gan and invigorating Pi acupuncture treatment on diarrhea-predominant irritable bowel syndrome.

Authors:  Jian-hua Sun; Xiao-liang Wu; Chen Xia; Lu-zhou Xu; Li-xia Pei; Hao Li; Guang-Yan Han
Journal:  Chin J Integr Med       Date:  2011-11-19       Impact factor: 1.978

Review 4.  The global impact of IBS: time to think about IBS-specific models of care?

Authors:  Maura Corsetti; Peter Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2017-07-31       Impact factor: 4.409

Review 5.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

6.  International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit.

Authors:  Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

Review 7.  A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Authors:  Jiyeon Lee; Eun-Hyun Lee; Seung Hei Moon
Journal:  Qual Life Res       Date:  2016-09-29       Impact factor: 4.147

8.  Patient-reported outcomes in gastroenterology: clinical and research applications.

Authors:  Brennan M R Spiegel
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

9.  Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey.

Authors:  Martín Cañón; Alvaro J Ruiz; Martín Rondón; Jaime Alvarado
Journal:  Ann Gastroenterol       Date:  2016-09-30

10.  Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group.

Authors:  Juan Carlos López-Alvarenga; William Orr; José Antonio Vargas-Romero; José María Remes-Troche; Miguel Morales-Arámbula; Julio César Soto-Pérez; Gualberto Mateos-Pérez; Sergio Sobrino-Cossío; Oscar Teramoto-Matsubara; Aurelio López-Colombo; Antonio Orozco-Gamiz; Adolfo Saez-Ríos; Araceli Arellano-Plancarte; Jazmin Chiu-Ugalde; Anne Tholen; Silke Horbach; Lars Lundberg; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.